Literature DB >> 2230994

Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S)methylpentadecanoic acid (BMIPP), in relation to ATP concentration.

Y Fujibayashi1, Y Yonekura, Y Takemura, K Wada, K Matsumoto, N Tamaki, K Yamamoto, J Konishi, A Yokoyama.   

Abstract

To clarify the relationship between the myocardial accumulation of 125I-15-(p-iodophenyl)-3-(R,S)-methylpentadecanoic acid (BMIPP) and intracellular adenosine-5'-triphosphate (ATP) content, the effect of 2,4-dinitrophenol (DNP, an electron transport uncoupler) on myocardial BMIPP accumulation was studied, in comparison with that of thallium-201-chloride (201Tl-Cl). In the mouse myocardium, DNP decreased the intracellular ATP and ADP levels, without affecting either acyl-CoA synthetase activity or the level of CoA-SH. Following treatment with DNP, decreases in myocardial BMIPP accumulation correlated well with those of ATP, while 201Tl-Cl showed slightly increased accumulation in the myocardium. Thus, in some diseases, BMIPP may be useful in evaluating myocardial ATP levels.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2230994

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  48 in total

Review 1.  Future aspects of BMIPP.

Authors:  N Tamaki; K Morita; E Tsukamoto; Y Kawai
Journal:  Int J Card Imaging       Date:  1999-02

2.  Detection of doxorubicin cardiotoxicity by using iodine-123 BMIPP early dynamic SPECT: quantitative evaluation of early abnormality of fatty acid metabolism with the Rutland method.

Authors:  K Saito; K Takeda; S Okamoto; R Okamoto; K Makino; Y Tameda; Y Nomura; H Maeda; T Ichihara; T Nakano
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

Review 3.  Targeted metabolic imaging to improve the management of heart disease.

Authors:  Moritz Osterholt; Shiraj Sen; Vasken Dilsizian; Heinrich Taegtmeyer
Journal:  JACC Cardiovasc Imaging       Date:  2012-02

4.  Role of BMIPP imaging for risk stratification in patients with coronary artery disease.

Authors:  Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

Review 5.  Rationale for the rational development of new cardiac imaging agents.

Authors:  D D Miller
Journal:  Ann Nucl Med       Date:  1993-11       Impact factor: 2.668

Review 6.  Metabolic imaging using SPECT.

Authors:  Junichi Taki; Ichiro Matsunari
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

7.  Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography.

Authors:  T Nishimura; S Nagata; T Uehara; T Morozumi; Y Ishida; T Nakata; O Iimura; C Kurata; Y Wakabayashi; H Sugihara; K Otsuki; T Wada; Y Koga
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

8.  Both total chain length and position of dimethyl-branching effect the myocardial uptake and retention of radioiodinated analogues of 15-(p-iodophenyl)-3,3-dimethylpentadecanoic acid (DMIPP).

Authors:  F F Knapp; M M Goodman; G Kirsch; S N Reske; J Kropp; H J Biersack; K R Ambrose; C R Lambert; A Goudonnet
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

9.  Clinical utility of myocardial fatty acid imaging in patients with end-stage renal disease.

Authors:  Masato Nishimura; Toshihiko Ono
Journal:  J Nucl Cardiol       Date:  2008-09-16       Impact factor: 5.952

10.  Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism.

Authors:  M Kawamoto; N Tamaki; Y Yonekura; E Tadamura; Y Fujibayashi; Y Magata; R Nohara; S Sasayama; K Ikekubo; H Kato
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.